Stock Market

Disney (NYSE:DIS) stock is down 27% year-to-date (YTD). To say the least, the market is not pleased with its earnings, especially its negative free cash flow. DIS stock probably won’t turn around until Disney can produce positive free cash flow. The market will be watching closely on May 11 when its Q2 earnings come out. Last

Matterport (NASDAQ:MTTR) on April 28 announced that it is opening new sales channels and increasing customer service operations in Japan. The expansion is great to see. But until the company is on better financial footing — or the markets are less uncertain — I wouldn’t put my money in MTTR stock just yet. In its news

While the benchmark ETF has printed the “death cross,” this should not cloud your decision-making process one way or the other. Certain phenomena are neither guaranteed to follow their stated implications or move in the contrarian direction. Especially under current ambiguous circumstances, it’s best to stay grounded in the fundamentals. Source: 22 TREE HOUSE /

Amazon (NASDAQ:AMZN) is down 15% since it released its first-quarter results on April 28. The online merchant had a massive outflow of free cash flow (FCF) in the last 12 months. This does not bode well for AMZN stock going forward. The reason is its FCF, after including repayments of finance leases and financing obligations, was

iBuying giant Opendoor Technologies (NASDAQ:OPEN) has suffered more than it deserved. In an attempt to transform the real estate industry, the company came under fire over the past few months and it reflected on OPEN stock. It is down 63% over the past six months and is trading below $10 today. The stock was once trading as

Twilio (TWLO) has surface-level appeal from a revenue-growth standpoint On the other hand, the company isn’t profitable, and is only digging a deeper financial hole for itself Investors should consider just avoiding Twilio altogether, even if they feel strongly about the future of cloud-based digital communications Source: Tada Images / Shutterstock.com At first glance, cloud-communications

Lucid (LCID) brings home some excellent news, confirming yet again that it can realistically stand up to its top rival. While myriad electric vehicle competitors have come out of the woodwork, LCID stock may be the most viable upstart opportunity. It all comes down to the realities of our current economic profile, which benefits Lucid

Costco (NASDAQ:COST) is an incredible retail machine. COST stock keeps on going up and up; it has nearly doubled since the beginning of 2020 and it’s up more than 200% over the past five years. This has started to attract some naysayers who say that Costco should be selling off like so many other companies that

The earnings train steams along. After a week of largely positive quarterly results from leading technology companies, the focus in the coming days turns to leading blue-chip companies, many of which are household names. Over the next week, we will hear from several top tier prescription drug makers, travel companies, technology companies, and food and

If the backdrop of electric vehicle (EV) focused shell company Gores Guggenheim (NASDAQ:GGPI) only featured soaring gasoline prices with all other factors being normal (as in pre-pandemic normal), then GGPI stock may very well be a buy. Who wouldn’t want to make the transition to EVs, especially in car crazy California, where the average per-gallon

After the market closed on April 26, Quantumscape (NYSE:QS) reported its results for the March quarter. QS stock has been up since then, but it should be noted that tech stocks overall rallied on April 28. Not only that, on the day of earnings, tech stocks were down big for the day. In short, it’s

WeWork (NYSE:WE) stock is down more than 2.51% today at $7.07 per share. The global co-working leader underperformed the market on the day and dipped 24.27% on the year, despite strong co-working demand. The company’s weak financials and high debt should continue to weigh on the stock in the near term as investors continue to dump

QuantumScape (QS) stock delivered a slightly larger loss than projected  The company is still over a year away from bringing a product to market  This range-bound stock may hold some intrigue for traders, but investors don’t need to rush in  Source: rafapress / Shutterstock The day after posting earnings, QuantumScape (NYSE:QS) is up slightly. Considering

Boston Beer (SAM): The malt beverages producer saw its sales by distributors to retailers decline by 7% due to decreasing hard seltzer demand. Peloton Interactive (PTON): The fitness company increased subscription fees to move the company closer to reaching breakeven on the bottom line. SoFi (SOFI): The personal finance company expects to grow Q1 adjusted

It’s going to take time for SoFi (SOFI) stock to start bouncing back. Even then, it may fail to bounce back to anywhere near its past all-time high. For now, the best move remains to wait for it to fall to a more “can’t miss” price. Source: Tada Images / Shutterstock.com After appearing to be

Disney (DIS) is ranked fourth in paid streaming services based on subscription numbers. Disney will have a hard time raising prices in the face of competition. The streaming skies are getting cloudier for DIS stock. Source: Shutterstock The bad news is that Walt Disney (NYSE:DIS) stock is down about 37% so far in 2022. The

Insider trading is a valuable metric for investors and can hint at future performance of these seven stocks. Alphabet (GOOG)(GOOGL): Co-founders’ sales accelerate, and executives joined them, but the insider trading signal remains weak. Lyra Therapeutics (LYRA): Insiders bought significant stakes in the clinical-stage biopharma play. CCC Intelligent Solutions (CCCS): Insiders and major investors are

T-Mobile (NASDAQ:TMUS) is expected to report earnings for the first quarter before the morning bell on Wednesday. Here’s what to be looking for with TMUS stock. Analysts are projecting revenue of $20.1 billion, which would be an increase of 1.5% from a year ago. Earnings-per-share is expected to come in at 32 cents, which would

Cassava Sciences, Inc. (NASDAQ:SAVA) is a clinical stage biotech firm. The company is focused on providing treatment for Alzheimer’s, a neurodegenerative disease. Its oral medicine, Simufilam, is in Phase 3 of clinical trials, pending approval for commercialization. The anticipated launch of this medicine has garnered investor interest. However, concerns have been raised about the quality

Monday morning was an interesting moment in the stock market. After trying to rotate over the prior week’s high early on Thursday morning, the S&P 500 rolled over…hard. Everything in its path, including Advanced Micro Devices (NASDAQ:AMD) was under pressure. Friday was even worse for the markets, although AMD stock fell less than 2% on